Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Electra Therapeutics Inc.

Electra Therapeutics Inc. (ETRA) Stock Overview

Explore Electra Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.

ETRA●NASDAQ
HealthcareMedical - Pharmaceuticals
$13.92
$0.67(5.06%)
U.S. Market opens in 2h 54m

Electra Therapeutics Inc. (ETRA)

Meyka AI Score

Z

Key Financials

Market Cap295.3M
P/E RatioN/A
EPS (TTM)$-2.65
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

ETRA Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Electra Therapeutics Inc. (NASDAQ: ETRA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Electra Therapeutics Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ETRA on the NASDAQ shows an RSI of 100.00, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.

Key metrics behind Electra Therapeutics Inc.'s NASDAQ-traded stock include a P/E ratio of N/A and a market capitalization of 295.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ETRA on the NASDAQ.

Price Performance (NASDAQ: ETRA)

1-Day Change
5.06%
5-Day Change
-7.20%
1-Month Change
-7.20%
3-Month Change
-7.20%
6-Month Change
-7.20%
Year-to-Date (YTD) Change
-7.20%
1-Year Change
-7.20%
3-Year Change
-7.20%
5-Year Change
-7.20%
All-Time (Max) Change
-7.20%

Contact Information

http://www.electra-therapeutics.com
NaN
NaN, South San Francisco, CA, NaN

Company Facts

IPO DateSep 18, 2026
CountryUS
Actively Trading

Frequently Asked Questions